KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Inventory (2016 - 2025)

Historic Inventory for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $3.2 billion.

  • Teva Pharmaceutical Industries' Inventory rose 572.0% to $3.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.2 billion, marking a year-over-year increase of 572.0%. This contributed to the annual value of $3.2 billion for FY2025, which is 572.0% up from last year.
  • As of Q4 2025, Teva Pharmaceutical Industries' Inventory stood at $3.2 billion, which was up 572.0% from $3.3 billion recorded in Q3 2025.
  • Teva Pharmaceutical Industries' 5-year Inventory high stood at $4.4 billion for Q1 2021, and its period low was -$147.0 million during Q4 2023.
  • For the 5-year period, Teva Pharmaceutical Industries' Inventory averaged around $3.6 billion, with its median value being $3.9 billion (2024).
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Inventory crashed by 10383.51% in 2023 and then soared by 214557.82% in 2024.
  • Over the past 5 years, Teva Pharmaceutical Industries' Inventory (Quarter) stood at $3.8 billion in 2021, then increased by 0.39% to $3.8 billion in 2022, then crashed by 103.84% to -$147.0 million in 2023, then soared by 2145.58% to $3.0 billion in 2024, then grew by 5.72% to $3.2 billion in 2025.
  • Its Inventory stands at $3.2 billion for Q4 2025, versus $3.3 billion for Q3 2025 and $3.5 billion for Q2 2025.